Opaxio

paclitaxel poliglumex · CTI Life Sciences Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Opaxio, covering 2009-09-23 to 2009-09-23. Get the full timeline:

Most recent: CTI Life Sciences Ltd. withdraws its marketing authorisation application for Opaxio (paclitaxel poliglumex)